1. Home
  2. WVE vs APAM Comparison

WVE vs APAM Comparison

Compare WVE & APAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.35

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo Artisan Partners Asset Management Inc.

APAM

Artisan Partners Asset Management Inc.

N/A

Current Price

$35.27

Market Cap

2.6B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
APAM
Founded
2012
1994
Country
Singapore
United States
Employees
N/A
567
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
WVE
APAM
Price
$13.35
$35.27
Analyst Decision
Strong Buy
Buy
Analyst Count
15
4
Target Price
$31.47
$47.00
AVG Volume (30 Days)
2.2M
603.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
10.67%
EPS Growth
N/A
10.66
EPS
N/A
4.05
Revenue
$3,704,000.00
$1,196,688,000.00
Revenue This Year
N/A
$7.55
Revenue Next Year
$119.93
$5.21
P/E Ratio
N/A
$8.96
Revenue Growth
149.43
7.63
52 Week Low
$5.28
$32.75
52 Week High
$21.73
$48.46

Technical Indicators

Market Signals
Indicator
WVE
APAM
Relative Strength Index (RSI) 47.54 20.98
Support Level $12.53 N/A
Resistance Level $14.56 $45.09
Average True Range (ATR) 0.79 1.17
MACD 0.01 -0.51
Stochastic Oscillator 23.84 1.63

Price Performance

Historical Comparison
WVE
APAM

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.

Share on Social Networks: